We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RV6 market cap is 10.47B. The company's latest EPS is USD 9.2430 and P/E is 23.98.
| Year End December 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.62B | 2.92B | 3.54B | 3.98B | 4.13B |
| Operating Income | 351.15M | 432.73M | 589.86M | 650.98M | 617.26M |
| Net Income | 252.02M | 364.3M | 390.98M | 486.23M | 474.62M |
| Year End December 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.69B | 5.49B | 7.02B | 7.6B | 8.2B |
| Total Liabilities | 3.03B | 3.35B | 4.43B | 4.58B | 4.54B |
| Total Equity | 1.64B | 2.12B | 2.54B | 2.98B | 3.6B |
| Year End December 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 480.94M | 546.58M | 760.8M | 619.64M | 683.9M |
| Investing | -681.5M | -601.54M | -1.44B | -607.92M | -563.16M |
| Financing | 231.94M | 47.25M | 672.6M | -42.4M | -85.52M |
| Market Cap | 10.47B |
| Price to Earnings Ratio | 23.98 |
| Price to Sales Ratio | 2.76 |
| Price to Cash Ratio | 41.13 |
| Price to Book Ratio | 3.11 |
| Dividend Yield | - |
| Shares Outstanding | 51.35M |
| Average Volume (1 week) | 24 |
| Average Volume (1 Month) | 22 |
| 52 Week Change | 5.73% |
| 52 Week High | 253.70 |
| 52 Week Low | 154.65 |
| Spread (Intraday) | 2 (0.98%) |
| Company Name | Charl Riv Labs Intl Dl 1 |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.criver.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
